scholarly journals Stromal Overgrowth in a Brenner Tumor or Ovarian Fibroma with Minor Sex Cord Elements?

2015 ◽  
Vol 22 (3) ◽  
pp. 366-368
Author(s):  
Julia A. Ross ◽  
Ozlen Saglam
2007 ◽  
Vol 67 (05) ◽  
Author(s):  
N Shabani ◽  
T Puchner ◽  
H Schütze ◽  
U Jeschke ◽  
I Mylonas ◽  
...  

1997 ◽  
Vol 37 (2) ◽  
pp. 333
Author(s):  
Soo Jin Kong ◽  
Myung Ho Rho ◽  
Byung Heon Kim ◽  
Yun Gyu Song ◽  
Soo Han Lee ◽  
...  
Keyword(s):  

1996 ◽  
Vol 62 (3) ◽  
pp. 408-410 ◽  
Author(s):  
Louise J. Perry ◽  
J.C. Lewis ◽  
R.Y. Ball
Keyword(s):  

2018 ◽  
Vol 13 (3) ◽  
pp. 63-65
Author(s):  
Amarnath Thakur ◽  
Ganesh Dangal ◽  
Aruna Karki ◽  
Hema Kumari Pradhan ◽  
Ranjana Shrestha ◽  
...  

Mucinous cystadenoma arises from the totipotent surface epithelium of the ovary. Its association with Brenner tumor suggests its origin as mucinous metaplasia of the epithelioid cells. The chance of malignancy is 5–10 percent. Patients usually present with abruptly increasing abdominal mass. Cystectomy is the management of choice in these cases. It was managed by laparoscopy.


2021 ◽  
pp. 106689692199945
Author(s):  
Christine J. Salibay ◽  
Valentina Zanfagnin ◽  
Heather Miller ◽  
Saloni Walia ◽  
Laurie L. Brunette ◽  
...  

Ovarian Brenner tumors, accounting for ∼5% of overall ovarian epithelial neoplasm, are often reported in association with mucinous neoplasm. Histogenetically, the two tumors are thought to arise from similar precursors. To date, fewer than 60 borderline Brenner tumors alone have been reported, and the concomitant presence of atypical proliferative components in Brenner and mucinous tumors is even rarer. Therefore, the clinicopathological characteristics and prognosis of patients with the borderline Brenner tumors alone or coexisting with mucinous neoplasm are extremely limited. Herein, we report a unique case of a 53-year-old woman with a unilateral ovarian borderline Brenner tumor associated with focal atypical mucinous epithelial proliferation and her clinical presentations. The clinicopathological features of the tumor are documented and the literature review along with the clinical molecular advances are summarized in this study.


2018 ◽  
Vol 20 ◽  
pp. e00082
Author(s):  
Luke King ◽  
Radhika P. Gogoi ◽  
Christopher Hummel ◽  
Ashlee Smith
Keyword(s):  

2009 ◽  
Vol 7 (3) ◽  
pp. 249-251
Author(s):  
Ravi Jumnoodoo ◽  
Jenny Lo ◽  
James English
Keyword(s):  

2012 ◽  
Vol 19 (6) ◽  
pp. S160
Author(s):  
S.-I. Park ◽  
E.-D. Lee ◽  
B.-J. Kim
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document